AKT1 and prostate cancer: Since PTEN is known as a lipid phosphatase that antagonizes the PI3K/AKT signaling pathway [7], we next treated prostate cancer cell lines PC3 and/or LNCaP cells with PI3K inhibitor LY294002 for hours as indicated.